Each year, the American Lung Association in California provides significant funding to support groundbreaking research right here in our state. This money supports basic and clinical research through training and "seed" grants for beginning researchers. These grants play a critical role in attracting and retaining talented scientists who are focused on lung research.
Many of our young scientists become award-winning researchers in the field of lung disease. The American Lung Association also funds the Airways Clinical Research Centers (ACRC) in San Diego, part of the nation's largest network of clinical research centers dedicated to lung disease treatment research. The ACRC conducts important clinical trials to improve lung disease management and treatment.
Please take a moment to learn more about our talented researchers below.
Airways Clinical Research Center
Smoking Asthmatics Pilot Study (SAPS)
Co-Funded by the National Institutes of Health's National Heart, Lung, and Blood Institute
About 20 percent of all people with asthma smoke. Smokers are consistently excluded from therapeutic trials for asthma. As a result, current asthma treatment guidelines may not be appropriate for smokers. Indeed, there is good evidence that inhaled corticosteroids, the mainstay for treating persistent asthma, are less effective in smokers. The SAPS trial is designed to test the feasibility of a large scale clinical trial looking at the four main therapeutic options for asthmatic patients who still smoke and are not well controlled on standard asthma therapy. Smoking cessation remains the primary strategy for treating these patients, but this study represents an important step in improving care for that significant population of individuals with asthma for whom smoking cessation remains a struggle.
"The treatment of asthma in patients who are smokers is an understudied area," said Joe Ramsdell, MD, (University of California, San Diego), SAPS Lead PI. "It is hoped that our study will lead to improved asthma care for smokers."